General Information of the Protein
Protein ID
PT06277
Protein Name
Probable G-protein coupled receptor 139
Secondarily
Protein Name
G(q)-coupled orphan receptor GPRg1
G-protein-coupled receptor PGR3
Gene Name
GPR139
Secondarily
Gene Name
GPRG1
PGR3
Sequence
MEHTHAHLAANSSLSWWSPGSACGLGFVPVVYYSLLLCLGLPANILTVIILSQLVARRQKSSYNYLLALAAADILVLFFIVFVDFLLEDFILNMQMPQVPDKIIEVLEFSSIHTSIWITVPLTIDRYIAVCHPLKYHTVSYPARTRKVIVSVYITCFLTSIPYYWWPNIWTEDYISTSVHHVLIWIHCFTVYLVPCSIFFILNSIIVYKLRRKSNFRLRGYSTGKTTAILFTITSIFATLWAPRIIMILYHLYGAPIQNRWLVHIMSDIANMLALLNTAINFFLYCFISKRFRTMAAATLKAFFKCQKQPVQFYTNHNFSITSSPWISPANSHCIKMLVYQYDKNGKPIKVSP
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
Function
Orphan receptor. Seems to act through a G(q/11)-mediated pathway.
    Show/Hide
Uniprot ID
Primary ID:
Q6DWJ6

Secondarily ID:
A8K5R9
Q86SP2
Q8TDU8
    Show/Hide
Ensembl ID
ENSG00000180269
HGNC ID
HGNC:19995
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000026 , CHO-K1
Compound ID Compound Name Compound Formula
CP0868363
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(8-(4-methylpiperazin-1-yl)-3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)acetamide
   Show/Hide
C20H23ClFN7O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0870177
(S)-N-(1-(4-chlorophenyl)ethyl)-2-(6-fluoro-3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C15H13ClFN5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0870178
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(5,7-dimethyl-3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C17H17ClFN5O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0870313
(S)-2-(5-methyl-3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C17H16F3N5O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0870328
(S)-2-(8-amino-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C17H19N5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0870331
(S)-2-(5-(3-hydroxyazetidin-1-yl)-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C20H20F3N5O4
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0870332
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(5-morpholino-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C20H21ClFN5O3
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0887597
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(5-(4-methylpiperazin-1-yl)-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C21H24ClFN6O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0903316
(S)-2-(7-methoxy-3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C17H19N5O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0903344
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(8-iodo-3-oxo-[1,2,4]triazolo[4,3-b]pyridazin-2(3H)-yl)acetamide
   Show/Hide
C15H12ClFIN5O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0903346
(S)-2-(6-methyl-3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C17H19N5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0911968
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(3-oxo-8-(piperidin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)acetamide
   Show/Hide
C20H22ClFN6O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0914629
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(6-fluoro-3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C15H12ClF2N5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0914630
(S)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C17H15F3N4O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0922696
(S)-2-(7-methyl-3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C17H16F3N5O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0942934
N-((S)-1-(4-chloro-3-fluorophenyl)ethyl)-2-(5-(3-methylmorpholino)-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C21H23ClFN5O3
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0942935
(S)-tert-butyl(3-oxo-2-(2-oxo-2-((1-(p-tolyl)ethyl)amino)ethyl)-2,3-dihydro-[1,2,4]triazolo[4,3-a]pyridin-8-yl)carbamate
   Show/Hide
C22H27N5O4
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0943679
N-((S)-1-(4-chloro-3-fluorophenyl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)propanamide
   Show/Hide
C16H15ClFN5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0943681
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)acetamide
   Show/Hide
C15H13ClFN5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0943682
(S)-N-(1-(3,4-dichlorophenyl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C15H13Cl2N5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0943687
(S)-2-(3-oxo-[1,2,4]triazolo[4,3-b]pyridazin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C16H14F3N5O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0943688
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(6-chloro-3-oxo-[1,2,4]triazolo[4,3-b]pyridazin-2(3H)-yl)acetamide
   Show/Hide
C15H12Cl2FN5O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0943697
(S)-N-(1-(4-(difluoromethoxy)-3-fluorophenyl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C17H15F3N4O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0954296
(S)-2-(8-chloro-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C17H17ClN4O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0955712
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(3-oxo-8-(piperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)acetamide
   Show/Hide
C19H21ClFN7O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0955715
(S)-N-(1-(4-chlorophenyl)ethyl)-2-(7-methoxy-3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C16H16ClN5O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0956047
(S)-N-(1-(4-chlorophenyl)ethyl)-2-(5,7-dimethyl-3-oxo-[1,2,4]triazolo[4,3-c]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C17H18ClN5O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0958445
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(6-methyl-3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C16H15ClFN5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0958447
(S)-N-(1-(4-chlorophenyl)ethyl)-2-(5,7-dimethyl-3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C17H18ClN5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0958688
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(8-methyl-3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)acetamide
   Show/Hide
C16H15ClFN5O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0958689
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(8-(oxetan-3-ylamino)-3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)acetamide
   Show/Hide
C18H18ClFN6O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0958693
(S)-2-(6-bromo-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C17H17BrN4O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0958694
(S)-2-(8-methyl-3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C17H16F3N5O3
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0958695
(S)-2-(6-methyl-3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C17H16F3N5O3
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0961052
(S)-2-(5-bromo-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C17H17BrN4O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0962196
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(7-iodo-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C16H13ClFIN4O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0962200
(S)-2-(3-oxo-[1,2,4]triazolo[4,3-c]pyrimidin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C16H17N5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0962207
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(8-(methylamino)-3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)acetamide
   Show/Hide
C16H16ClFN6O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0962208
(S)-N-(1-(4-chlorophenyl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C16H15ClN4O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0964630
(S)-N-(1-(4-chloro-3-fluorophenyl)ethyl)-2-(5-(3,3-difluoroazetidin-1-yl)-3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C19H17ClF3N5O2
 1
1
EC50 < 1 nM
   TI
   LI
   LO
   TS
CP0969626
(S)-2-(5,7-dimethyl-3-oxo-[1,2,4]triazolo[4,3-c]pyrimidin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C18H21N5O2
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0870310
(S)-N-(1-(4-cyclopropylphenyl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-b]pyridazin-2(3H)-yl)acetamide
   Show/Hide
C18H19N5O2
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0870312
(S)-2-(3-oxo-6-(piperidin-1-yl)-[1,2,4]triazolo[4,3-b]pyridazin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C21H23F3N6O3
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0903218
(S)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C16H17N5O2
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0903315
(S)-N-(1-(4-chlorophenyl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C15H14ClN5O2
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0903317
(S)-N-(1-(4-isopropoxyphenyl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C19H22N4O3
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0914625
(S)-N-(1-(4-(difluoromethoxy)-3-fluorophenyl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)acetamide
   Show/Hide
C16H14F3N5O3
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0955717
(S)-2-(3-oxo-5-(piperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C21H23F3N6O3
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0956044
N-((4-chlorophenyl)(cyclopropyl)methyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C18H17ClN4O2
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0958696
(S)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide
   Show/Hide
C16H14F3N5O3
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0962194
(S)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyrimidin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C16H17N5O2
 1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
CP0870299
2-(3-oxo-8-(pyrrolidin-3-yl)-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)-N-((S)-1-(p-tolyl)ethyl)acetamide
   Show/Hide
C21H25N5O2
 1
1
EC50 >= 100 nM
   TI
   LI
   LO
   TS
CP0943684
(S)-N-(1-(5-fluoropyridin-3-yl)ethyl)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)acetamide
   Show/Hide
C15H14FN5O2
 1
1
EC50 >= 100 nM
   TI
   LI
   LO
   TS
CP0960360
(S)-2-(8-(azetidin-3-yloxy)-3-oxo-[1,2,4]triazolo[4,3-a]pyrazin-2(3H)-yl)-N-(1-(4-chloro-3-fluorophenyl)ethyl)acetamide
   Show/Hide
C18H18ClFN6O3
 1
1
EC50 >= 100 nM
   TI
   LI
   LO
   TS
CP0960979
(R)-2-(3-oxo-[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)-N-(1-(p-tolyl)ethyl)acetamide
   Show/Hide
C17H18N4O2
 1
1
EC50 >= 100 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( G-protein-coupled receptor PGR3 (GPR139) )
Target Type Clinical trial Target
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID Protein Name Protein Organism
PT06789 Probable G-protein coupled receptor 139 Rattus norvegicus, Rat